First-in-human trial of MK-8591-eluting implants demonstrates concentrations suitable for HIV prophylaxis for at least one year R. P. Matthews,S. E. Barrett,M. Patel, W. Zhu, K. L. Fillgrove, L. Haspeslagh, G. Chen, V. Levine, S. Zhang,A. Goodey,S. P. Forster, R. Vargo,J. A. Grobler,S. A. Stoch,M. IwamotoJOURNAL OF THE INTERNATIONAL AIDS SOCIETY（2019）引用 40|浏览14暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
